Dr. Megan Coylewright, an interventional cardiologist, is Director of the Structural Heart Program at The Erlanger Heart and Lung Institute in Chattanooga, TN. Dr. Coylewright’s research focused on diversity, equity and inclusion compliments her role as Vice Chief of Cardiology for Faculty Development within southern Tennessee’s only academic cardiovascular program. She lectures widely on her research focused on designing clinical trial outcomes for structural heart device trials and the science of shared decision making. Dr. Coylewright completed her medical school and residency at Johns Hopkins, with her cardiovascular training spent at Mayo Clinic in her home state of Minnesota.